Polymer Capital Management HK LTD purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, Holdings Channel reports. The fund purchased 8,100 shares of the company’s stock, valued at approximately $1,041,000.
A number of other institutional investors also recently bought and sold shares of MKGAF. Madison Wealth Partners Inc bought a new position in Merck KGaA during the second quarter valued at $1,031,000. Keating Financial Advisory Services Inc. bought a new stake in shares of Merck KGaA in the 2nd quarter worth about $592,000. Tocqueville Asset Management L.P. purchased a new position in shares of Merck KGaA during the 2nd quarter worth about $57,546,000. August Group Capital Ltd purchased a new position in shares of Merck KGaA during the 2nd quarter worth about $390,000. Finally, Great Lakes Advisors LLC bought a new position in Merck KGaA during the 2nd quarter valued at about $183,444,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Stock Performance
Merck KGaA stock opened at $163.21 on Monday. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56. The company’s 50-day moving average is $162.62 and its 200 day moving average is $148.44. The firm has a market capitalization of $21.09 billion, a P/E ratio of 24.92 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
